Sickle Cell Anemia and Cerebral Microcirculation : Multimodal Exploration
NCT ID: NCT02909283
Last Updated: 2018-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
64 participants
OBSERVATIONAL
2015-03-02
2017-07-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cerebrovascular Reserve Measurements in Sickle Cell Disease
NCT02824406
Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease
NCT02445144
Cerebrovascular Reserve and White Matter Disease in Patients with Chronic Anemia
NCT03715972
Impact of Severe Brain Injury on Neuro-vascular and Endothelial Regulation of Peripheral Microcirculation.
NCT04597879
Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition
NCT06090201
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sickle cell disease patients
Physical exams and blood analyzes
Physical exams and blood analyzes
Blood samples collection (for DNA, plasma and cells analyzes) ; Hemorheologic analyzes ; ASL sequence on MRI ; Near Infra Red Spectroscopy (NIRS) and associated cardiofrequency analyze.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical exams and blood analyzes
Blood samples collection (for DNA, plasma and cells analyzes) ; Hemorheologic analyzes ; ASL sequence on MRI ; Near Infra Red Spectroscopy (NIRS) and associated cardiofrequency analyze.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 6-16 years;
* steady state;
* normal TCD (Transcranial Doppler);
* parental study approval and written informed consent.
Exclusion Criteria
* history of overt stroke,
* intracranial or cervical arterial stenosis,
* abnormal TCD at the time of the study.
6 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hopital Universitaire Robert-Debre
OTHER
Imagine Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valentine Boursse
Role: PRINCIPAL_INVESTIGATOR
Hôpital Necker-Enfants Malades
Suzanne Verlhac
Role: STUDY_DIRECTOR
Centre Hospitalier intercommunal de Créteil
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Intercommunal
Créteil, , France
Necker - Enfants Malades hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMIS2014-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.